These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37580940)

  • 1. Preparation and evaluation in vitro of doxorubicin loaded mimetic exosomes-based delivery system.
    Suna He -; Haofeng Pan -; Xingyue Qian -; Junyang Zhang -; Runfang Zhang -
    Pak J Pharm Sci; 2023 May; 36(3):895-900. PubMed ID: 37580940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
    Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
    Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells.
    Uslu D; Abas BI; Demirbolat GM; Cevik O
    Mol Divers; 2024 Apr; 28(2):449-460. PubMed ID: 36576666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
    Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
    Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
    Li M; Wang J; Guo P; Jin L; Tan X; Zhang Z; Zhanghuang C; Mi T; Liu J; Wang Z; Wu X; Wei G; He D
    Biomater Adv; 2022 Nov; 142():213161. PubMed ID: 36308859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
    Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
    Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress.
    Yang Y; Chen Y; Zhang F; Zhao Q; Zhong H
    Int J Hyperthermia; 2015; 31(5):498-506. PubMed ID: 25955015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
    Gong C; Tian J; Wang Z; Gao Y; Wu X; Ding X; Qiang L; Li G; Han Z; Yuan Y; Gao S
    J Nanobiotechnology; 2019 Sep; 17(1):93. PubMed ID: 31481080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
    Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
    Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    El-Ghareb WI; Swidan MM; Ibrahim IT; Abd El-Bary A; Tadros MI; Sakr TM
    Int J Pharm; 2020 Aug; 586():119514. PubMed ID: 32565281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
    Haque ST; Islam RA; Gan SH; Chowdhury EH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells.
    Srivastava A; Amreddy N; Babu A; Panneerselvam J; Mehta M; Muralidharan R; Chen A; Zhao YD; Razaq M; Riedinger N; Kim H; Liu S; Wu S; Abdel-Mageed AB; Munshi A; Ramesh R
    Sci Rep; 2016 Dec; 6():38541. PubMed ID: 27941871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.
    Li Y; Gao Y; Gong C; Wang Z; Xia Q; Gu F; Hu C; Zhang L; Guo H; Gao S
    Nanomedicine; 2018 Oct; 14(7):1973-1985. PubMed ID: 29935333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 15. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison.
    Wu JY; Li YJ; Hu XB; Huang S; Luo S; Tang T; Xiang DX
    J Control Release; 2021 Aug; 336():510-521. PubMed ID: 34237399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
    Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis.
    Kanchanapally R; Deshmukh SK; Chavva SR; Tyagi N; Srivastava SK; Patel GK; Singh AP; Singh S
    Int J Nanomedicine; 2019; 14():531-541. PubMed ID: 30666112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived exosomes can specifically prevent cancer metastatic organotropism.
    Xie X; Lian S; Zhou Y; Li B; Lu Y; Yeung I; Jia L
    J Control Release; 2021 Mar; 331():404-415. PubMed ID: 33485883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The In-Situ One-Step Synthesis of a PDC Macromolecular Pro-Drug and the Fabrication of a Novel Core-Shell Micell.
    Yu CY; Yang S; Li ZP; Huang C; Ning Q; Huang W; Yang WT; He D; Sun L
    Curr Pharm Des; 2016; 22(4):506-13. PubMed ID: 26517529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.